Why Hyderabad is the world’s vaccine capital
為何海得拉巴是世界疫苗之都？
HYDERABAD: As international vaccine companies and academic institutions race the clock to deliver a safe Covid-19 vaccine, all eyes are on India that makes 60% of the world’s vaccines. And within India, if there is one destination that all of them are making a beeline for it is Hyderabad. The city has the capacity to churn out well over a third of the global vaccine supply.
海得拉巴：當國際疫苗公司和學術機構爭分奪秒地研製安全的新冠疫苗時，所有人的目光都集中在印度，該國生產的疫苗佔世界的60%。在印度國內，如果有一個目地方是所有人都直奔的目的地，那就是海得拉巴。這座城市有能力生產遠超全球三分之一的疫苗供應。
Be it India’s first indigenous Covid-19 vaccine candidate Covaxin or Russia’s Sputnik V, Johnson & Johnson’s Ad26.Cov2.S, FluGen’s CoroFlu or even Sanofi’s under development vaccine candidates, all have a Hyderabad connect.
無論是印度本土的首款新冠候選疫苗Covaxin，還是俄羅斯的Sputnik V，強生公司的Ad26.Cov2.S、FluGen的CoroFlu還是賽諾菲正在開發的候選疫苗，都與海得拉巴有聯繫。
Whether a successful Covid-19 vaccine is developed in Hyderabad or not, a vaccine developed anywhere in the world will be churned out of Hyderabad, says Dr Varaprasad Reddy, founder & chairman, Shantha Biotechnics Ltd.
Shantha生物技術公司創始人兼董事長Varaprasad Reddy博士說，無論是否在海得拉巴研製成功新冠肺炎疫苗，世界上任何地方研製的疫苗都將在海得拉巴生產。
「All Hyderabad vaccine companies are robust in manufacturing technology and have the capacity to manufacture millions of doses with good standards,」 says Reddy, who is awaiting Sanofi’s own vaccine candidate in the first half of 2021, a chunk of which is expected to be manufactured in Hyderabad. Sanofi had acquired Shantha Biotechnics in 2009.
Reddy說:「海得拉巴的所有疫苗公司在生產技術上都很強大，有能力以高標準生產數百萬劑疫苗。」他正在等待賽諾菲的候選疫苗在2021年上半年生產，其中大部分預計將在海得拉巴生產。賽諾菲在2009年收購了Shantha生物技術公司。
Hyderabad will be an integral part of the Covid-19 solution just by the dint of the sheer vaccine manufacturing capacity it houses, feels Mahima Datla, managing director, Biological E Limited, which has a tieup with Baylor College of Medicine, Texas, to develop its own vaccine candidate and a tech collaboration to manufacture Johnson & Johnson’s vaccine here.
Biological E公司董事總經理Mahima Datla認為，僅憑海得拉巴擁有的疫苗生產能力，海得拉巴就將成為新冠解決方案的一個組成部分。該公司與德克薩斯州貝勒醫學院合作開發自己的候選疫苗，並在本土與強生公司合作生產疫苗。
『Hyderabad well poised to offer affordable Covid solution』
海德拉巴準備提供負擔得起的新冠解決方案
IIL deputy MD Prasanna Deshpande feels that as affordability will be the key in battling Covid-19 given its global spread, no one is better poised to offer this than Hyderabad given its scale of operations. The Telangana government too is gung-ho about Hyderabad’s role in the Covid-19 battle given. 「Being the vaccine capital of the world, we are fully committed to playing an enabling role in global vaccination efforts against Covid-19 and proactively support our companies to quickly ramp up production to serve the world,」 said Jayesh Ranjan, principal secretary, industries & ITE&C, Telangana.
印度免疫公司副總Prasanna Deshpande認為，鑑於疫情在全球傳播，負擔能力將是抗擊疫情的關鍵，鑑於其業務規模，沒有比海得拉巴更有能力提供這種服務的地方。泰倫加納政府也對海得拉巴在抗疫戰鬥中所扮演的角色非常支持。泰倫加納的Industries & ITE&C首席秘書Jayesh Ranjan說:「作為世界疫苗之都，我們全力致力於在全球抗擊新冠肺炎的疫苗接種工作中發揮積極作用，並積極支持企業迅速提高產量，以服務世界。」
印度時報讀者的評論：
譯文來源：三泰虎 http://www.santaihu.com/p/50819.html 譯者：Jessica.Wu
C S Maurya
I hope by Diwali our Vaccination program will start
希望到排燈節，我們能開始接種疫苗
Surrender das Moti
God willing my friend
朋友，那只能看天意了
Leon Fernandes
that is good news. Hyderabad is making India proud. ambient city. we wool forward to the city making headlines in the near future.
好消息，海得拉巴給印度人帶來了自豪感。我們期待著在不久的將來，海得拉巴上全球頭條。
Nissangahan
Is this a paid news? I was under the impression that in India, SII is the biggest manufacturer of vaccines.
這是花錢請人寫的文章嗎?
在我的印象中，印度血清研究所才是印度最大的疫苗製造商。
Vanya Pranavi
Indian idiots can only replicate and copy ..they cannot make anything on their own.. morons...
印度白痴只會山寨，沒有原創。
Cuber
You r one among them
你也是他們中的一員
Manu R
What about Pune ??? Forgotten Serum Institute of India ???
普納呢?
印度血清研究所被遺忘了??
D CAA
So Fauci is right in saying that US will have to wait till mid 21 for covid vaccine.
美國傳染病專家Fauci說美國要等到2021年年中才有疫苗。
Rajesh
hope for the best to happen by hyderabad to deliver the medicine
希望海得拉巴能儘快生產疫苗，希望一切順利
Sambappa Kalvala
Companies are looking forward to mint money by releasing vaccine
製藥公司希望通過生產疫苗來賺錢
Aj Jey
70% of raw materials in form of APIs come from China...what are we dancing for? did Doland command you to go to Balconies and bhajaothalli?
70%的原料藥來自中國…我們有什麼好歡喜的?
Ashish Kumar
Serum Inst of India at Pune is worlds largest vaccine manufacturing facility-so the headline is quiet mis guiding.
位於普納的印度血清研究所是世界上最大的疫苗製造商，所以標題有誤導性。
Charlie Harper
Hope they havent hired ppl with fake degrees
希望他們沒有僱拿假文憑的人
Tamal Chaudhuri
I am bot sure if Hyderbad is the worlds vaccine capital but india definitely makes 60% of the worlds vaccines. This has been like this for a long time so the credit goes to the previous governments
我不確定海德巴德是否是世界疫苗之都，但世界60%的疫苗肯定是在印度生產的，這種情況已經持續了很長一段時間，所以這要歸功於前任政府
Jai Ram
Vaccines for a fake ficitous nonexistential disease called covid...??
為一種不存在的病毒生產疫苗？
Tanmoy Kar
Good to know that India is manufacturing 60% of the vaccines of the World.
很高興得知世界上60%的疫苗都是印度生產的。
Nitin De
Secular State of Maharashtra has More than 2-Lakhs ACTIVE Cases As Against All Other States Less than 1-Lakh??
國大黨執政的馬哈拉施特拉邦確診超過20萬例，而其他邦不到10萬
Amit Laddha
Covid virus mutates very fast , so by time you took vaccine , the virus must have already mutated to various other genetic forms. So its impossible to have a vaccine which can kill all the mutated forms of covid..instead one should focus on proper medication and eat better food to develop immune system.
新冠病毒變異非常快，到你接種疫苗時，病毒肯定已經變異成各種其他的基因形式了。所以不可能靠疫苗能殺死所有變異的病毒，相反，人們應該關注適當的藥物治療，改善飲食，提高免疫力。
real India
India steal, copy and pirate on R&D results of others to boast itself world largest, best, all rubbish. Shameless
印度竊取、抄襲、剽竊其他國家的研發成果，吹噓自己是全球之最，無恥
Rajesh Singhal
True, India has Hyderabad as the vaccine capital of the country. But India has always been the Capital of so many,like India is the Capital of Diabetes, total drugs across the world is smuggled into India with Delhi as its Crime Capital, too.
的確，海得拉巴是疫苗之都。但是印度一直是「各種」之都，比如糖尿病之都，新德裡是犯罪之都，還有全世界的藥物都被走私到印度。
三泰虎 http://www.santaihu.com 從這裡了解印度人對中國的看法